FDA Inspection
Robert B. Molpus, M.D.Robert B. Molpus, M.D. – FDA Inspection, Aug 28, 2026
Record Details
This FDA Inspection record concerns Robert B. Molpus, M.D., with an inspection on August 28, 2026, issued by the Florida District Office, covering human drugs.
View Company Profile
ID · bf51b9bd-7f4c-4138-a96b-09d60a44c2c2
Inspection Facts
- Inspection number
- 1333912
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Robert B. Molpus, M.D.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 3, 2025 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 10, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 26, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Robert B. Molpus, M.D.
- FDA Inspection 1266065 - 2025-04-03
- FDA Inspection 1127812 - 2020-08-10
- FDA Inspection 1039869 - 2018-01-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.